Adiponectin, visfatin and regional fat depots in normal weight obese premenopausal women

European Journal of Clinical Investigation

Volumn 43, Issue 8, 2013, Pages 783-790

  Miazgowski, Tomasz ^a   Safranow, Krzysztof ^a   Krzyzanowska Świniarska, Barbara ^a   Iskierska, Katarzyna ^a   Widecka, Krystyna ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Adipokines; Body fat; Lipid profiles; Normal weight obesity

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TRIACYLGLYCEROL;

ABDOMINAL FAT; ADULT; ARTICLE; BLOOD PRESSURE; BODY FAT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; LIPID STORAGE; MAJOR CLINICAL STUDY; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL;

EID: 84880746029     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12106     Document Type: Article

References (35)

1. Blüher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010;21:38-43.
2. Messier V, Karelis AD, Prud'homme D, Primeau V, Brochu M, Rabasa-Lhoret R et al. Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity (Silver Spring) 2010;18:911-7.
3. Conus F, Allison DB, Rabasa-Lhoret R, St-Onge M, St-Pierre DH, Tremblay-Labeau A et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 2004;89:5013-20.
4. De Lorenzo A, Martinoli R, Vaia F, Di Renzo L. Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutr Metab Cardiovasc Dis 2006;16:513-23.
5. Marques-Vidal P, Pécoud A, Hayoz D, Paccaud F, Mooser V, Waeber G et al. Normal weight obesity: relationship with lipids, glycaemic status, liver enzymes and inflammation. Nutr Metab Cardiovasc Dis 2010;20:669-75.
6. Romero-Corral A, Somers VK, Sierra-Johnson J, Korenfeld Y, Boarin S, Korinek J et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J 2010;31:737-46.
7. Marques-Vidal P, Pécoud A, Hayoz D, Paccaud F, Mooser V, Waeber G et al. Prevalence of normal weight obesity in Switzerland: effect of various definitions. Eur J Nutr 2008;47:251-7.
8. Di Renzo L, Galvano F, Orlandi C, Bianchi A, Di Giacomo C, La Fauci L et al. Oxidative stress in normal-weight obese syndrome. Obesity (Silver Spring) 2010;18:2125-30.
9. Cook JR, Semple RK. Hypoadiponectinemia - cause or consequence of human "Insulin Resistance"? J Clin Endocrinol Metab 2010;95:1544-54.
10. Saddi-Rosa P, Oliveira CS, Giuffrida FM, Reis AF. Visfatin, glucose metabolism and vascular disease: a review of evidence. Diabetol Metab Syndr 2010;2:21.
11. Friebe D, Neef M, Kratzsch J, Erbs S, Dittrich K, Garten A et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 2011;54:1200-11.
12. Garten A, Petzold S, Barnikol-Oettler A, Körner A, Thasler WE, Kratzsch J et al. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes. Biochem Biophys Res Commun 2010;391:376-81.
13. Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006;49:1909-14.
14. Dogru T, Sonmez A, Tasci I, Bozoglu E, Yilmaz MI, Genc H et al. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 2007;76:24-9.
15. Uslu S, Kebapçi N, Kara M, Bal C. Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus. Exp Ther Med 2012;4:113-20.
16. Gok DE, Yazici M, Uckaya G, Bolu SE, Basaran Y, Ozgurtas T et al. The role of visfatin in the pathogenesis of gestational diabetes mellitus. J Endocrinol Invest 2011;34:3-7.
17. Sethi JK, Vidal-Puig A. Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends Mol Med 2005;11:344-7.
18. Chen CC, LI TC, Li CI, Liu CS, Lin WY, Wu MT et al. The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women. Metab, Clin Exp 2007;56:1216-20.
19. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, Shin SJ et al. Elevated plasma level of visfatin/Pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006;91:295-9.
20. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. 2006. Available at: http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf. Accessed on 21 September 2006.
21. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
22. Anastasiou CA, Yannakoulia M, Pirogianni V, Rapti G, Sidossis LS, Kavouras SA. Fitness and weight cycling in relation to body fat and insulin sensitivity in normal-weight young women. J Am Diet Assoc 2010;110:280-4.
23. Kwon S. Association between abdominal obesity and cardiovascular risk factors in normal-weight Korean women. Health Care Women Int 2009;30:447-52.
24. Ferreira I, Snijder MB, Twisk JW, van Mechelen W, Kemper HC, Seidell JC et al. Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and Health Longitudinal Study. J Clin Endocrinol Metab 2004;89:2632-9.
25. Parker ED, Pereira MA, Stevens J, Folsom AR. Association of hip circumference with incident diabetes and coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2009;169:837-47.
26. Lee K, Lee S, Kim YJ, Kim YJ. Waist circumference, dual-energy X-ray absorptiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women. Nutrition 2008;24:625-31.
27. Zhu S, Wang ZM, Shen W, Heymsfield SB, Heshka S. Percentage body fat ranges associated with metabolic syndrome risk: results based on the third National Health and Nutrition Examination Survey (1988-1994). Am J Clin Nutr 2003;78:228-35.
28. Colombo O, Villani S, Pinelli G, Trentani C, Baldi M, Tomarchio O et al. To treat or not to treat: comparison of different criteria used to determine whether weight loss is to be recommended. Nutr J 2008;7:5.
29. Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond) 2010;7:26.
30. Nakamura Y, Sekikawa A, Kadowaki T, Kadota A, Kadowaki S, Maegawa H et al. Visceral and subcutaneous adiposity and adiponectin in middle-aged Japanese men: the ERA JUMP Study. Obesity (Silver Spring) 2009;17:1269-73.
31. Esteghamati A, Alamdari A, Zandieh A, Elahi S, Khalilzadeh O, Nakhjavani M et al. Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity. Diabetes Res Clin Pract 2011;91:154-8.
32. Indulekha K, Anjana RM, Surendar J, Mohan V. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113). Clin Biochem 2011;44:281-7.
33. Zhaoxia L, Ying W, Danqing C. Changes in visfatin levels after oral glucose tolerance test in women with gestational diabetes mellitus. Diabetes Res Clin Pract 2012;96:e76-9.
34. Martos-Moreno GÁ, Kratzsch J, Körner A, Barrios V, Hawkins F, Kiess W et al. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism. Int J Obes (Lond) 2011;35:1355-62.
35. Al-Attas OS, Hussain T, Al-Daghri NM, Rosas ED, Kazmi U, Vinodson B. The relationship between a Mediterranean diet and circulating adiponectin levels is influenced by cigarette smoking. J Atheroscler Thromb 2013. Published on 2012 Dec 27. Article ID: 14837. Available at: http://dx.doi.org/10.5551/jat.14837. Accessed on 27 December 2012.